AVLN vs JANX: stock comparison and AI forecast
Avalyn Pharma Inc. (AVLN) and Janux Therapeutics, Inc. (JANX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVLN Avalyn Pharma Inc.
- Price
- $25.63 -2.9% · 6M
- Market Cap
- $1.14B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
JANX Janux Therapeutics, Inc.
- Price
- $17.82 +24.4% · 6M
- Market Cap
- $1.09B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AVLN and JANX have similar market capitalizations ($1.14B and $1.09B).
- Over the last six months JANX returned +24.4% and AVLN -2.9%.
- JANX carries 0.09 times debt per unit of equity, against 0.07 times for AVLN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVLN | JANX |
|---|---|---|
| Market Cap | $1.14B | $1.09B |
| P/B Ratio | 2.85x | 1.17x |
| EPS | – | $-1.63 |
| Book Value/Share | $8.99 | $15.18 |
| Revenue/Share | – | $0.33 |
| FCF/Share | – | $-0.69 |
Profitability & Margins
| Metric | AVLN | JANX |
|---|---|---|
| ROE | – | -11.1% |
| ROA | – | -10.2% |
| ROIC | – | -15.2% |
| Operating Margin | – | -708.3% |
| Net Margin | – | -506.2% |
| EBT Margin | – | -708.3% |
Financial Health
| Metric | AVLN | JANX |
|---|---|---|
| Current Ratio | 33.12x | 16.35x |
| D/E Ratio | 0.07x | 0.09x |
| Financial Leverage | 1.07x | 1.09x |
| Working Capital | $347M | $923M |
Cash Flow
| Metric | AVLN | JANX |
|---|---|---|
| Operating Cash Flow | – | -$41M |
| Free Cash Flow | – | -$42M |
| Capital Spending | – | -$670K |
| FCF/Sales | – | -206.9% |
| CapEx/Sales | – | 3.3% |
Operational Efficiency
| Metric | AVLN | JANX |
|---|---|---|
| Asset Turnover | – | 0.02x |
| Receivables Turnover | – | 136.0x |
| Fixed Assets Turnover | – | 6.2x |
| Days Sales Outstanding | – | 3 days |
Income Statement
| Metric | AVLN | JANX |
|---|---|---|
| Total Revenue | – | $20M |
| Operating Income | – | -$144M |
| Net Income | – | -$103M |
| R&D Expense | – | $124M |
Dividend & Shareholder Information
| Metric | AVLN | JANX |
|---|---|---|
| Shares Outstanding | 44M | 61M |
AVLN vs JANX: stock comparison and AI forecast
Which is bigger, AVLN or JANX?
AVLN and JANX have similar market capitalizations ($1.14B and $1.09B).
Which stock performed better over the last six months, AVLN or JANX?
Over the last six months JANX returned +24.4% and AVLN -2.9%.
Which one does Intratio's AI model rank higher, AVLN or JANX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.